The journal

Everything we've published.

Reporting, explainers, and news from across the six pillars we cover.

Refine by tag

A small amber pill bottle with a blank label lying on its side on a linen cloth beside a glass of water, in soft morning light.

Low-Dose Naltrexone: A Small Dose, A Large Set of Claims

A fifty-year-old opioid blocker, prescribed at a tenth of its approved dose for fibromyalgia, long COVID, ME/CFS and MS. The mechanistic story is elegant, the trial record is messier — and 2026 delivered an uncomfortable correction to the field’s most-cited positive number.

Revuelt Health · October 20, 2026 · 10 min read

Read

A dim living room at night, a single warm lamp glowing beside an armchair with a folded blanket and a glass of water on a small tray.

Latest

Psychedelic Therapies

Ketamine by Mail: What the Evidence Supports — and What the At-Home Boom Assumed

The clinic evidence for ketamine in depression is real and randomized. The booming at-home telehealth version is built on a different drug product, different doses, no head-to-head trials — and regulators have started saying so out loud.

Revuelt Health · October 20, 2026 · 10 min read

Read

A minimalist wellness clinic lobby in soft daylight, with a curved boucle armchair, pale oak floors, a stone reception desk and potted olive trees.

Latest

Clinics & Destinations

Longevity Clinics: What You Are Actually Buying, and What the Trials Actually Show

A quarter-million blood tests, full-body MRI, epigenetic clocks, NAD+ drips and off-label rapamycin, priced from $199 a year to $19,000 and up. The geroscience behind the boom is real research. Almost none of it has been shown to extend a human life.

Revuelt Health · October 20, 2026 · 11 min read

Read

A rustic ceramic bowl of ground ashwagandha root powder beside dried roots and green leaves on a dark stone surface.

Latest

Alternative Medicine

Ashwagandha: What the Trials Actually Show — and What the Regulators Found

The adaptogen is one of the most-studied botanicals on the supplement shelf, with more than $165 million in annual U.S. sales. The stress data is better than most herbs can claim, the safety story is worse than most buyers assume, and one European country has made it illegal to sell.

Revuelt Health · October 20, 2026 · 10 min read

Read

A phlebotomist's gloved hands drawing a blood vial in a bright clinical lab, soft morning light on glass vials in the foreground.

Latest

Medical Breakthroughs

Blood Tests for Alzheimer’s Are Finally Real. Here Is What They Do — and Don’t — Change.

Four FDA-cleared blood assays for Alzheimer’s pathology now exist, with the newest cleared for use in primary care. The accuracy data is genuinely good for symptomatic patients. Almost everything the internet claims about the numbers is still wrong.

Revuelt Health · October 20, 2026 · 10 min read

Read

A quiet still life on a pale wooden surface in soft morning light: a shallow ceramic dish holding dried seed pods, a folded length of unbleached linen, and a plain glass of water catching the window.

Chronic & Complex Illness

Fecal Transplants Beyond C. diff: What Is Approved, What Is Promising, and What Got Harder to Get

Transferring a healthy person's gut microbes into a sick person's colon is an approved, guideline-backed treatment — for exactly one condition. This year the field finally produced randomized data outside that condition, a regulator said no to the most advanced product in Europe, and a manufactured alternative matched donor stool in a head-to-head trial. None of it points the same direction.

Revuelt Health · September 15, 2026 · 13 min read

Read

Folded linen, ceramic vessels and a wooden recovery tool in soft natural daylight.

Sister brand

The same standard, applied to objects.

Revuelt Health reports. Revuelt makes. Our sister brand builds a small collection of rest and recovery tools with the same rule we apply to research here — no exaggerated claims, no invented mechanisms, nothing that needs marketing language to sound useful. We don’t review their products, and nothing they sell affects what we cover.

Visit Revuelt →

The dispatch

Join our list — new writing on the frontier of medicine, in your inbox.

Considered emails, never more than you want. Research, clinics, and what the evidence currently supports. No hype, no unsubscribing guilt.